within Pharmacolibrary.Drugs.N_NervousSystem.N06B_PsychostimulantsAgentsUsedForAdhdAndNootropics.N06BA15_DexmethylphenidateAndSerdexmethylphenidate;
model DexmethylphenidateAndSerdexmethylphenidate 
   extends Pharmacolibrary.Drugs.ATC.N.N06BA15;

  annotation(Documentation(
    info ="<html><body><p>Dexmethylphenidate is the d-threo-enantiomer of methylphenidate, a central nervous system stimulant indicated for the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adults. Serdexmethylphenidate is a prodrug of dexmethylphenidate designed for extended-release formulations. The combination is approved and marketed for the treatment of ADHD.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for healthy adults based on known pharmacokinetics of dexmethylphenidate and serdexmethylphenidate (CNS stimulant, oral administration). No published non-compartmental or compartmental population PK modeling reports currently available; estimates extrapolated from clinical pharmacology data.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end DexmethylphenidateAndSerdexmethylphenidate;
